{"name":"Achieve Life Sciences","slug":"achieve-life-sciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":22817000,"netIncome":-54648000,"cash":41790000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"OGX-427 1000 mg","genericName":"OGX-427 1000 mg","slug":"ogx-427-1000-mg","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"OGX-427 1000 mg","genericName":"OGX-427 1000 mg","slug":"ogx-427-1000-mg","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOY0txNGgza0tNdlpFaUVPSVJsYjlCSVBSRGs4MnNqVzBZdUdtZ2lvV3pyUWVqejVNUVBiRHg2a1M0OU1MeHZpamtSRF9veTZYM01EWjhhdW9HTzg3ODhhNWVPMng5X1hKX1BGN1k0czRYZFAweGw4Y3V5RmVvcGJBSW42THpVbjFZcWRaSGRIaTJkV1RJeE1ZUXBsamx0bWZwbW9Z?oc=5","date":"2026-04-01","type":"pipeline","source":"Seeking Alpha","summary":"Achieve Life Sciences: The Recent Sell-Off Skews The Outcomes (NASDAQ:ACHV) - Seeking Alpha","headline":"Achieve Life Sciences: The Recent Sell-Off Skews The Outcomes (NASDAQ:ACHV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxPcDNrdnNLbTQ4cGJMS2hnM0JSM3JSTmVtaVpmR0stMkZ2ZzYyOWJBMzR2S1lvUmUzSFZzX1JqZlZ0dy1VWUxXdXFTUmlZNXpnT1A2WFc0WXhIS2phSjZDTWMxSHZ2ZzRHVmF3SzVJankxNlVPbW1kNnBlOTJlZkFoTkdBZ2RQWXV2SG1PZ2szeGttNElVUWdVMUJDQWU4aWo4VTlUZVVjem9seEZaV0wxZGJXVko0bHRqWkxueXQwTEdiR2VtNHVwcng0OEQ2UUV3SzMzY3FXWktxZ3Q4eDJZTzZrT0M1WnF1T2tiZ0ZlaC11a3ZRTEJqYi1yN3ZFdWd2bjNuZS1IYVF1UWZHZ2FTMVF2dzA?oc=5","date":"2026-03-26","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on Top Healthcare Stocks: KalVista Pharmaceuticals (KALV), Achieve Life Sciences (ACHV) - The Globe and Mail","headline":"Analysts Are Bullish on Top Healthcare Stocks: KalVista Pharmaceuticals (KALV), Achieve Life Sciences (ACHV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxQQ0tjcVE0UTB5TUV6TlFOdXF4c0RDTmZENVVQN2M0anpYZjR6dHVwS21oeTdXUWtCYW9qNGtfQVUtNnMtTVZkNWozLUpDNExRNG1TSzBkY09Gdmg1SXpfS1RLWkwxUVIzdVFScDJmR2puZHpCMG9iUXRiamVyVHA5MmNSMDh1TFJLa3RULTI0QVBLXzNKcU0ybFJzd0RTbEJzLVBuMmJaYUJlakNQbUhRcmVJc0FJYzBNVmdZTTV2SWZLYWZiOUJtRl82MVh4N0N2V2FMMzdVSkJnNERQVFRqOHhxX1BhWWZPQklHRWRjR2hueU1SRlVTN2JIQk1tc0JHZlIzempCV3ZEVjg1NFQzbg?oc=5","date":"2026-03-24","type":"earnings","source":"GlobeNewswire","summary":"Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewswire","headline":"Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQWXVxVWhweGttNEFJQXpVTG9Id1NCMnZsSDRnQk16SWloTzFRV1ZwcDBQTHU1UnZmMFFkbFJRbFM2YmV0SXpsSHVKX2wxLTRnYy1jNWE3Nk5hRjhqS0hUZXhqb3lRaGtaSGNZWHdhQzJIRjRCckhKZjRtdWQ1WUFxQkpoeV9ZMzVTQ2RlRXh5NmI5bm95dFcyQ2ZHVkh0dkhkUmtaWUZyeWdyUTNBY0Fab3dYcy0?oc=5","date":"2026-03-24","type":"regulatory","source":"Stock Titan","summary":"Achieve Life Sciences (NASDAQ: ACHV) deepens 2025 loss while eyeing 2026 FDA decision - Stock Titan","headline":"Achieve Life Sciences (NASDAQ: ACHV) deepens 2025 loss while eyeing 2026 FDA decision","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOcFJnNVFXWWxMdUNReHZhTU5SLU9XUEpMcS10QlQ4QWgtVmtnaWxiVHpZTEc3NGxBUzlaVnB5djBGWWh0R3I2RnF4aHl2M0tXaEdKQVlPRnZXdkE2Y3RnekJLMTdROG55VFRqSVJtT2hPbi1fWTF2cGN3NkNCS1J2c0hnNkZ5T3BLdnU0YTJoQVFNMWQ0RTNGQWI1Rk93Y1VhOTZMaUVSTjdMbnBzdDk5dTZvY3FKV1NjRGc?oc=5","date":"2026-03-24","type":"regulatory","source":"Stock Titan","summary":"Achieve taps U.S. manufacturer for quit-smoking pill ahead of FDA date - Stock Titan","headline":"Achieve taps U.S. manufacturer for quit-smoking pill ahead of FDA date","sentiment":"neutral"},{"date":"2026-03-24","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1Bc2wtMENoMFF4bmpMRVBGTU5uMU9pWVMzdDdNU00zTV9nd3BVNXRNRzVSQ0JxYlBVZUpVWEQ2bmgyT2l6TUhSRXBLRWVvM1A0YWpuODhVX28teGMzb0HSAWNBVV95cUxOSnNUaHhhdzZYT3FkLWdUNWczakdaajFBcnNyWC13eTFxNUctYUdDVnFDdzJVd0RRRjhraFhQQmF3WW5QbUpvVDVrbXZWQ0c0TkZaYnlqMDE4R25ydi1ub19VSlU?oc=5","date":"2026-03-23","type":"earnings","source":"Bitget","summary":"Achieve Life Sciences’ 2025 Q4 Call: NDA Timeline Shifts, Vaping Launch Strategy, and Supply Readiness Claims Don’t Match - Bitget","headline":"Achieve Life Sciences’ 2025 Q4 Call: NDA Timeline Shifts, Vaping Launch Strategy, and Supply Readiness Claims Don’t Matc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPVkI3RXAzeXJ1dGNDRDkySVZLNDVYRWNDTXhNME5fRGhPWDU4SUFTUm9zcVdDM0ZhVC1tbVNCaXA1X3Q3YkhIdVM1aV8yTDIxckFIVjRpX2k4Rk45Z1RDaFJ4dy1QZDhNcjUzU212LVQwb3E0VWZXSVBCaDJEdE1SYkZFTkIxZXoyRXZRR0M3VElndjgtQmdkUmgyRzhMcHg0Zzg2RGZKWQ?oc=5","date":"2026-02-10","type":"pipeline","source":"AI News","summary":"Agentic AI in healthcare: How Life Sciences marketing could achieve $450B in value by 2028 - AI News","headline":"Agentic AI in healthcare: How Life Sciences marketing could achieve $450B in value by 2028","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQeGxlOFNGQnJyNnJfTHlHbEhnQmVVR2R3V3JqSmE3eVpxYUtkel9QY0s4WEJjWmNLYnFNNmYzZGRxaFZZMXJwb0h5T0lGeERhY3Y5alViQTBWWE53ODg0VzY0T25HQkx6WG9iQS1rOUtGMFhHQnZ3Q2VzRjd2UE1tcFZkS01aY1dQaF83SFlYbjdNQ2ROaU4wYmc2bS1zWHVlRlZoTHVrelVHM295a19mTVVFbVJZUQ?oc=5","date":"2026-02-04","type":"pipeline","source":"Seeking Alpha","summary":"Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch - Seeking Alpha","headline":"Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQRWtWbzkySWZwdjhnUTdiUlZPdWxhZ3c5bTJISWFmWGU3bjkzSGVFR3JnMFNZMENIaEw1M1VHbUx3V0NIZkVPMk8tUTFRMHJ1SWVSaFlZOFhtVG5sNy1lRmpPd2s0eXdadm0wd0NlbFlzWF85Ykp4SHl1Y2hKSGxHS0xLUGhUYWl4MnNMMlZtd3ZxUTA4R24yNmp3UHE5YzZodl91ZFhCb3ZWYkF3enlJTlhfZWVtcmRuT0stV3FzV1pEM2FOZmxCd1NOcFhhbWwxY0VGbHprLS0?oc=5","date":"2026-01-07","type":"pipeline","source":"Ad Age","summary":"11 creative campaigns to know about today - Ad Age","headline":"11 creative campaigns to know about today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQYUI3VGtuMHFnNEpqMGtKYjktZHhQT2JGcEJDN2ZuQnpoc25zTW84RExDTlotdjV0MURsMC1NRmI2dXd3Q1NDWEJHc19YMlhPQjNDb1M0Zmh5WkNlTEVnbHFBY2F2dVh1M0NlMHVyWW1UWnN3bTduN190UmhiZXJOS1k2Y2FZZw?oc=5","date":"2025-11-25","type":"regulatory","source":"Yahoo Finance","summary":"FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation - Yahoo Finance","headline":"FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation","sentiment":"neutral"},{"date":"2025-11-06","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-11-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-10-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":0,"revenuePeriod":"2019-12-31","revenueHistory":[{"value":0,"period":"2019-12-31"},{"value":0,"period":"2018-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":22817000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-54648000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":41790000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}